Congratulations! The innovation of Professor Tzu-Ming Pan and SunWay Biotech is awarded “Advanced National Innovation Award” on 1 Dec 2020!
- Author: sunway
- Category: Company News
We, Innovators
The innovation of Professor Tzu-Ming Pan and SunWay Biotech “The Red Yeast Rice- Improvement of Memory and Learning Abilities of Alzheimer’s Patients” was awarded the National Innovation Award in 2008. With the continuous innovation, specific research, and development process for promotion worldwide, this application has been twice awarded the “Advanced National Innovation Award” on 1 Dec 2020!
Advanced National Innovation Award
Advanced National Innovation Award
Advanced National Innovation Award
Advanced National Innovation Award
Related posts
ANKASCIN® 568-R red yeast rice extract shows benefits to manage total cholesterol and LDL-C
The first clinical study, which has been published in the Journal of Food and Drug Analysis, documents that ANKASCIN® 568-R is effective in reducing subjects’ serum cholesterol and low-density lipoprotein cholesterol (LDL-C) to nearly desirable levels in as little as 4 weeks and were maintained in 8 weeks. Forty subjects (Inclusion criteria: LDL-C in the range of 130-190 mg/dL and serum cholesterol greater than 180 mg/dL) completed the double-blind, placebo-controlled randomized 12-week study. The administration group took 110 mg ANKASCIN® 568-R/one capsule/day for eight weeks. After four weeks of treatment (110 mg ANKASCIN® 568-R/day), the changes in the lipid levels showed that the active products had a more favorable effect than the placebo. Compared to the baseline, statistically significant decreases of 11.9% and 19.0% were observed in TC and LDL-C levels, respectively (p < 0.05 for all pairs). This study demonstrated that subjects administered 110 mg of ANKASCIN® 568-R for more than four weeks exhibited a significant reduction in serum TC and LDL-C levels. To assess the safety of this ingredient, scientists assayed aspartate transaminase (AST) and alanine aminotransferase (ALT) levels in the liver, and blood urea nitrogen (BUN), creatinine, and uric acid levels in the kidney. The results imply no significant effect on renal metabolism and physiological function. These results indicate that supplementation of ANKASCIN® 568-R reduces the risks of serum TC and […]
- Author: sunway
- Category: Company News
Exciting News! NIANGJIA Monascus Capsule is the first product of Taiwan recognized as a finalist for the Nutraingredient Asia Awards 2023: Botanical Product of the Year!
🌟 Exciting News! NIANGJIA Monascus Capsule is the first product of Taiwan recognized as a finalist for the Nutraingredient Asia Awards 2023: Botanical Product of the Year! 🌟 The specialty of #ANKASCIN568R is that it contains high levels of Monascin and Ankaflavin, showing anti-glycation, anti-inflammatory, and antioxidant abilities via #PPAR and #Nrf2 pathways to improve hyperglycemia, preventing fatty plaque accumulation for cardiovascular health, and ameliorating pathogenesis of Alzheimer’s decline to enhance cognitive function, having beneficial effects for healthy aging benefits. We are grateful to our dedicated R&D teams and the unwavering support from our valued customers. Let’s root for NIANGJIA Monascus Capsule to win the championship together! 💪 #NutraingredientAsia #Finalist #antiaging #CardiovascularHealth #BloodSugarManagement #NIUawards23 #RedYeastRice
- Author: sunway
- Category: Company News
SunWay Biotech had earned recognition from President Tsai of Taiwan
President Tsai Ing-wen met the 2022 Outstanding Biotechnology Industry Award winners on 23rd February. She emphasized that the government will continue to invest resources and adjust and amend relevant laws and regulations to improve the competitiveness of the biotechnology and medical industry continuously. Thus, technology and medical enterprises will develop more vigorously and create more welfare for the public. SunWay Biotech is committed to applying diverse and effective microorganisms and developing efficient and unique fermentation processes to provide high-quality products that ensure carefree health across the globe. In addition to winning the Taiwan BIO Award-Advanced National Innovation Award” for two consecutive years in 2020 and 2021, SunWay was honored to be awarded the Gold Award of 2022 Taiwan BIO Award! SunWay was invited to meet with President Tsai and discuss with the President and other participants how to continuously improve the competitiveness of the biotechnology and medical industry and become Taiwan’s next trillion-dollar industry! President John Pan of SunWay Biotech also expressed his gratitude to every colleague, customer, shareholder, and the most important technological inventor, Professor Tzu-Ming Pan, for allowing SunWay to create another sacred mountain for Taiwan! Source: Office of the President
- Author: sunway
- Category: Company News